Get Your Personalized Supplement StackSupplement Stack Quiz

Acacia catechu

Also known as: Acacia catechu (L.f.) Willd., Khair, Black Catechu, Cutch tree, Acacia catechu

Overview

Acacia catechu is a deciduous tree native to Asia, traditionally utilized in Ayurvedic and other traditional medicine systems for its diverse therapeutic properties. Extracts derived from its heartwood, bark, and leaves are rich in bioactive compounds, including catechins, flavonoids, and tannins. These constituents contribute to its primary applications as an antimicrobial, anti-inflammatory, antioxidant, antidiabetic, hepatoprotective, and analgesic agent. While research on A. catechu is moderately developed, with numerous in vitro and in vivo studies, and some clinical investigations, there is a current limitation in the number of systematic reviews and meta-analyses. It is commonly used as a herbal supplement and botanical extract.

Benefits

Acacia catechu offers several evidence-based benefits, primarily attributed to its rich content of flavonoids and tannins. It exhibits strong antioxidant activity, with leaf and heartwood extracts demonstrating free radical scavenging capabilities comparable to or superior to standard antioxidants like BHT and mannitol. This suggests potential in reducing oxidative stress, which is implicated in neurodegenerative diseases. The methanolic extracts have shown significant anti-inflammatory and analgesic effects in animal models, with dose-dependent pain relief at 200-400 mg/kg, sometimes outperforming aspirin. Bark extracts have demonstrated bacteriostatic and antibacterial activity against periodontal pathogens such as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans at low concentrations (0.2-100 μg/ml), indicating potential for oral health applications. Animal studies also suggest antidiabetic and antihyperglycemic effects, including blood glucose lowering and improved lipid profiles, though human data are currently sparse. Furthermore, extracts have shown hepatoprotective and antiulcer properties in animal models, likely through their antioxidant and anti-inflammatory mechanisms.

How it works

The pharmacological effects of Acacia catechu are largely attributed to its high content of flavonoids and tannins. These compounds primarily act as potent antioxidants by donating electrons or hydrogens to neutralize reactive oxygen species (ROS), thereby reducing oxidative stress. For its anti-inflammatory effects, A. catechu is believed to suppress pro-inflammatory mediators and enzymes, although specific molecular targets require further elucidation. Its antimicrobial action likely involves disrupting bacterial cell walls and inhibiting bacterial growth, as demonstrated by minimum inhibitory concentration (MIC) and time-kill assays against oral pathogens. The catechins and tannins present in A. catechu have moderate bioavailability, and their systemic effects can be influenced by metabolism and interactions with gut microbiota.

Side effects

Acacia catechu extracts are generally considered safe at traditional doses, with animal studies reporting low toxicity. However, common side effects are not well-documented in clinical settings due to a lack of extensive human trials. No significant drug interactions or contraindications have been definitively established. Nevertheless, caution is advised due to the tannin content, which may potentially affect iron absorption. Individuals with iron deficiency or those taking iron supplements should consult a healthcare professional. There is insufficient safety data for special populations, including pregnant or lactating women and children, and therefore, its use in these groups is not recommended without medical supervision. Comprehensive safety warnings and long-term effects in humans require further research.

Dosage

Currently, there are no established human dosing guidelines for Acacia catechu derived from high-quality randomized controlled trials. Animal studies have utilized doses ranging from 50-400 mg/kg body weight to achieve analgesic and antioxidant effects. For consistency and efficacy, extract standardization by catechin or tannin content is recommended. The timing of administration and the specific formulation (e.g., methanolic versus aqueous extracts) can significantly influence bioactivity and absorption. Without robust human clinical data, it is challenging to specify precise dosage ranges, timing considerations, or different dosages for various purposes. Upper limits and safety thresholds for human consumption are also not well-defined, emphasizing the need for further research before widespread clinical recommendations can be made.

FAQs

Is Acacia catechu effective for pain?

Animal studies indicate significant analgesic effects from Acacia catechu extracts at moderate doses, with some research suggesting efficacy comparable to or exceeding aspirin in certain pain models. However, human clinical trials are needed to confirm these findings.

Can it be used for oral infections?

In vitro studies support the antimicrobial activity of Acacia catechu bark extract against key periodontal pathogens, suggesting its potential as an adjunctive treatment for oral infections. Clinical trials are required to validate its effectiveness in humans.

Is it safe long-term?

While traditional use suggests a degree of safety, comprehensive clinical safety data for long-term use of Acacia catechu in humans are currently insufficient. More research is needed to establish its long-term safety profile.

How quickly do benefits appear?

Animal studies show acute effects from Acacia catechu within hours to days, depending on the specific benefit being studied. However, there is a lack of human data to determine how quickly benefits might appear in people.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9697042/ – This systematic review from Plants (2022) examined various pharmacological activities of A. catechu extracts, including antioxidant, anti-inflammatory, analgesic, and antimicrobial effects. It highlighted dose-dependent antinociceptive activity in mice, showing up to 69.6% writhing reduction at 400 mg/kg, but noted the primary limitation of mostly preclinical data and absence of human RCTs.
https://www.benthamdirect.com/content/journals/cbc/10.2174/0115734072330468241124184555 – This comprehensive review from Bentham Science (2024) summarized the ethnobotanical uses and pharmacology of A. catechu. It confirmed its antibacterial, antidiabetic, and anti-inflammatory properties, while emphasizing the critical need for further clinical trials and detailed toxicity studies to validate its therapeutic potential.
https://rjds.journalgrid.com/view/article/rjds/300 – This in vitro antimicrobial study from RJDS (2024) demonstrated the bacteriostatic and antibacterial effects of A. catechu bark extract against common periodontal pathogens. It reported minimum inhibitory concentration (MIC) values as low as 0.2 μg/ml, indicating strong activity, but stressed that the findings are limited to in vitro conditions without clinical trial data.
https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0150574 – This study from PLoS One (2016) investigated the antioxidant activity of A. catechu leaf extract. It showed strong DPPH radical scavenging and hydroxyl radical neutralization, suggesting neuroprotective potential, and utilized validated biochemical assays with statistical significance (p<0.05) to support its findings.
https://www.tandfonline.com/doi/abs/10.1080/27697061.2022.2145525 – This research from Tandfonline (2022) explored a formulation containing A. catechu and Scutellaria baicalensis for immune support against influenza. However, the study's details were limited, and the observed effects could not be solely attributed to A. catechu, making it difficult to draw specific conclusions about its individual contribution.